Scaling Femtech in Europe

Join an inspiring conversation uniting key players from the Femtech ecosystem, including breakthrough biotech founders and institutional leaders, to discuss the pathways for scaling women's health innovations. With historically underfunded sectors gaining traction, this event will shed light on the vast market potential in areas like diagnostics, therapeutics, digital health, and medtech tailored for female biology.

What to Expect:

• The European Landscape: A comparative examination of France and Spain, delving into regulatory dynamics, ecosystem maturity, and emerging opportunities.
• Market Access & Funding: Strategies for unlocking growth in a category still establishing its scaling and reimbursement pathways.
• Institutional Advocacy: Insights on how national organizations are driving the transition from innovation to standard of care.

Featured Innovators:

• Womed: Pioneering next-generation intrauterine therapies.
• Peekcell: Innovating simple solutions for women’s cancer screening.
• Aspivix: Introducing a modern, soft-suction cervical device as a gentler alternative to traditional methods.
• Femtech Spain: Represented by a board member actively shaping the national ecosystem.

This event is proudly organized by Capital Cell and VCLS. After the roundtable, join us for a networking cocktail hour to connect with panelists, startups, and the Capital Cell team. Don't miss this opportunity to engage and collaborate in the Femtech space! 🍹